About

Dr. Massimo Lazzeri is a leading urologic surgeon and researcher whose work has significantly advanced the fields of uro-oncology and minimally invasive surgery. His research is centered on improving surgical outcomes for prostate and kidney cancers, as well as pioneering robotic techniques for complex reconstructive urology. Dr. Lazzeri is best known for developing the Margin, Ischemia, and Complications (MIC) Score, a novel system for evaluating the quality of partial nephrectomy (148 citations), and for his seminal work validating the Prostate Health Index (phi) and its derivative %p2PSA as powerful predictors of pathologic outcomes in prostate cancer (124 and 88 citations). These contributions have provided surgeons with critical tools for both surgical planning and postoperative assessment. He has also been a trailblazer in robotic surgery, demonstrating the feasibility and efficacy of robot-assisted laparoendoscopic single-site (R-LESS) pyeloplasty and ureteral reconstruction, with several studies reporting excellent outcomes (78, 60, 52, and 34 citations). With over 750 citations across his most influential papers, Dr. Lazzeri’s work continues to shape clinical practice, offering patients safer, more precise, and less invasive treatment options.

Research Focus

Key Achievements

16
H-Index
32
Papers
956
Total Citations
30
Avg Citations/Paper
🏆 Most Cited Paper
Margin, Ischemia, and Complications (MIC) Score in Partial Nephrectomy: A New System for Evaluating Achievement of Optimal Outcomes in Nephron-sparing Surgery
148 citations · 2012
📈 Most Prolific Year: 2024 (6 Papers)
🤝 Key Collaborators: 126
🏛 Institutions: Vita-Salute San Raffaele University, Humanitas University, San Raffaele University of Rome, IRCCS Humanitas Research Hospital

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago